Obesity Digestive System Obesity
Conditions
Interventions
Patients will be randomly assigned to one of two groups:
1. Exercise group: moderate intensity exercise combining aerobic and resistance exercise
1.1 Pre-intervention (baseline) assessment
1.2. 12 wee
patients will be offered an optional exercise programme of their choice (e.g., home based, walking outside, gym or swimming)
and they will be given a diet information sheet
1.6. 6 month follow-up assessment
2. Control group
2.1. Pre-intervention (baseline) assessment
2.2. 12 weeks of no structured exercise
2.3. Post-interv
patients will be offered an exercise programme of their choice (e.g., home based, gym or swimming)
and they will be given a diet information sheet
2.5. 6 month follow-up assessment
Sponsors
University of Leicester
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18–60 years old 2. Had bariatric surgery in past 12–24 months 3. Body-mass index (BMI) of at least 30 kg/m2 (=28 kg/m2 for South Asian people) 4. Completion of a stress test and approval from an in-house clinician in accordance with our standard operating procedure and document
Exclusion criteria
Exclusion criteria: 1. Highly active individuals or individuals meeting current physical activity guidelines (self-report of =2·5 hours per week) 2. Unstable diabetes 3. Orthopaedic limitations 4. Motor neurone disease 5. Stage II hypertension (systolic blood pressure >60 mmHg and/or diastolic blood pressure >100 mmHg) 6. Cardiovascular disease: coronary artery disease, cardiomyopathy, heart failure, cor pulmonale, cardiac dysrhythmias, endocarditis, myocarditis, valvular heart disease, cerebrovascular disease, peripheral arterial disease, congenital heart disease and rheumatic heart disease 7. Pulmonary disease: inflammatory lung disease, obstructive lung disease, chronic obstructive pulmonary disease, emphysema, cystic fibrosis, respiratory tract infections, pleural cavity disease and pulmonary vascular disease 8. Renal disease 9. Chair bound 10. Weight limit of 200 kg or greater
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incremental shuttle walk test (metres): will be measured at baseline, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Grip strength (kg), measured with a analogue hand grip dynamometer 2. Seat to stand test (seconds), using a 5 x seat to stand protocol 3. Body composition: measured using Tanita bioelectrical impedance scales (BC-418-MA) 4. Height (cm), measured by a SECA stadiometer 5. Weight (kg), measured by Tanita bioelectrical impedance scales (BC-418-MA) 6. Waist and hip circumference (cm), measured with a SECA tape measure 7. Physical activity, measured by Actigraph GT3X+ accelerometer 8. Self-reported physical activity, measured with the Short form International Physical Activity Questionnaire (IPAQ) 9. Blood pressure (mmHg), measured with an automated Intelle sense blood pressure machine (arm cuff) 10. Resting heart rate (beats per minute), measured with a finger pulse oximeter 11. Oxygen saturation (%), measured with a finger pulse oximeter 12. Dietary intake, measured with a 24-hour food recall 13. Self-efficacy, measured using the self-efficacy to regulate physical activity (SERPA) questionnaire 14. Anxiety and depression measured with the Hospital Anxiety and Depression Scale (HADS) 15. Medications and doses: obtained from medical notes 18. Cholesterol, measured with venous blood specimens 19. High-density lipoprotein, measured with venous blood specimens 20. Low-density lipoprotein, measured with venous blood specimens 21. Triglycerides, measured with venous blood specimens 22. Non-fasting glycated haemoglobin, measured with venous blood specimens All these outcomes will be measured at baseline, 3 months and 6 months. | — |
Countries
United Kingdom
Contacts
Public ContactLouisa Herring
Outcome results
None listed